SCHEMBL20288052

SCHEMBL20288052

Fc1cc(Cl)ccc1COc1nc(N2CCNCC2)ccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 3/20 0.51
▸ HTR3E A5X5Y0 2/20 0.51
▸ HTR3B O95264 2/20 0.51
▸ HTR3D Q70Z44 2/20 0.51
▸ HTR3C Q8WXA8 2/20 0.51
▸ PRMT5 O14744 1/20 0.44
▸ MCHR1 Q99705 2/20 0.44
▸ HTR2C P28335 5/20 0.43
▸ HTR2A P28223 3/20 0.43
▸ HTR2B P41595 3/20 0.43
▸ GLP1R P43220 1/20 0.43
▸ INPPL1 O15357 1/20 0.42
▸ HTR1A P08908 3/20 0.42
▸ ADRB1 P08588 2/20 0.42
▸ HTR7 P34969 2/20 0.42
▸ SLC6A4 P31645 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28973080 0.99 HTR3A (0.50) HTR3AHTR3EHTR3BHTR3DHTR3C
Trifluoroacetic Acid SCHEMBL30662711 0.91 GLP1R (0.45) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24455369 0.85 GLP1R (0.48) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL29687310 0.85 GLP1R (0.48) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24147365 0.85 INPPL1 (0.41) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL20267507 0.85 GLP1R (0.48) MCHR1GLP1RPRKCQPRKCD
SCHEMBL20267509 0.85 GLP1R (0.48) MCHR1GLP1RPRKCQPRKCD
SCHEMBL24147695 0.84 INPPL1 (0.50) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24147522 0.84 HTR2A (0.53) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL22402421 0.84 HTR3A (0.46) HTR3AHTR3EHTR3BHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391760-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-12-07 — — US disclosed
EP-3555064-B9 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER (US) 2023-03-01 — — EP disclosed
WO-2022078407-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-04-21 — — WO disclosed
WO-2018109607-A1 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER INC. (US) 2018-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391760-A1 HETEROCYCLIC GLP-1 AGONISTS GLP1R, GIPR, GCGR HTR3A 104/4885HTR3E 183/4885HTR3B 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback